Epic Update Sun Pharmaceutical
NCDEX Tips Stock Market News stock tips

Sun Pharma climbs 2% on USFDA approval

Sun Pharmaceutical advanced as much as 2.17 percent on Thursday as the pharma major got a go-ahead from the US Food and Drug Administration (USFDA) for its ophthalmic drug.

For Real Time News & Trading Trends Keep Liking Epic Research Limited

Facebook

Twitter

YouTube

Pinterest

Linkedin

Google+

Share Button
Epic Research
Epic Research
Epic Research - Investment Adviser is a leading financial services provider with presence in Indian and other global capital markets. Call on - 0731-664-2300
https://www.epicresearch.co/